arrow
P

Parul Doshi

University of Barcelona
H指数:25
被引数:2,915

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trial

纳武利尤单抗联合化疗或伊匹木单抗治疗胃癌和食管癌:一项随机III期试验的探索性生物标志物分析

2025-03-070
OA
Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens
2019-07-1135
OAAI
Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1β in tumor-associated macrophages

乳腺肿瘤衍生的CCL2通过上调肿瘤相关巨噬细胞中的IL1β 来增强促转移性全身炎症

2017-06-1992
OAAI
The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia-Microenvironment Interactions in Chronic Lymphocytic Leukemia
2017-03-1453
OAAI
CNTO 95, a fully human anti αv integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells

CNTO 95是一种完全人抗 α v整合素抗体,可抑制人乳腺癌细胞的细胞信号传导,迁移,侵袭和自发转移

2007-12-0591
PREAI